Burrill & Company
Burrill & CompanyFounded: 1985
Number of deals: 15
Number of companies: 15
Scoop: Burrill & Company, which invests exclusively in the life sciences, manages funds totaling over $950 million. The San Francisco-based firm primarily invests in the United States and Europe. Managers at Burrill & Co. prefer early-stage opportunities, but invest across the industry, including in therapeutics, diagnostics, medical device companies, bioprocesses and biomaterials. The firm is currently investing its sixth fund, Burrill Life Sciences Capital Fund III, which closed in 2006 at $283 million.
Portfolio Company News:
Emerging Drug Developer: Neurotech
Emerging Drug Developer: Aerovance
Burrill: Biotech achieves profitability as crisis bites ...
Tengion raises $21M for second close of Series C
Osprey gathers $11M in first round
SHARE
WITH: